Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Gilead Sciences
Biotech
Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders
Sanofi CSO Nestle exits. Pfizer names Citi analyst to chief strategy role. Acelyrin's founding CEO departs.
Max Bayer
,
Gabrielle Masson
May 10, 2024 8:30am
Gilead gives up on $4.9B antibody magrolimab
Apr 26, 2024 10:04am
Gilead dives deeper into Nurix protein degrader collab
Apr 2, 2024 9:10am
Gilead pays $43.5M for Xilio's early-phase IL-12 prospect
Mar 28, 2024 8:08am
Merck-Gilead's weekly HIV combo maintains viral suppression
Mar 6, 2024 11:08am
Gilead bets $1.5B-plus on Merus' trispecifc T-cell engagers
Mar 6, 2024 10:02am